A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer
pmc.ncbi.nlm.nih.gov/articles/PMC12643885/Posted Dec 1, 2025, 4:01 AM UTC
20
pmc.ncbi.nlm.nih.gov
Loading comments…
Posted Dec 1, 2025, 4:01 AM UTC